BCL-6 expression during B-cell activation.

From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer (2009) 4.15

Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol (2010) 3.48

IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One (2011) 2.92

BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev (2000) 2.83

The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol (2005) 2.42

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24

Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev (1998) 2.23

Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17

Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00

STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol (2008) 1.97

Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol (1999) 1.91

Signals that influence T follicular helper cell differentiation and function. Semin Immunopathol (2010) 1.62

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.62

Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med (2009) 1.61

Dynamics of B cells in germinal centres. Nat Rev Immunol (2015) 1.61

BCL6 is critical for the development of a diverse primary B cell repertoire. J Exp Med (2010) 1.56

Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles. Immunity (2009) 1.49

B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr Opin Hematol (2008) 1.47

The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A (2002) 1.43

Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med (2007) 1.41

In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat Commun (2011) 1.41

Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med (2012) 1.40

BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J Exp Med (2003) 1.36

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med (1999) 1.29

OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J (1998) 1.25

Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J (2001) 1.23

BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol Dis (2008) 1.21

AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. Mol Cell (2010) 1.16

Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur J Immunol (2010) 1.12

Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol (2011) 1.11

Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells. Blood (2008) 1.04

Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm (2011) 1.04

Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology (2006) 1.03

Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol (2014) 1.02

Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo. J Virol (2004) 1.01

Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01

IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells. Immunol Cell Biol (2012) 0.98

Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci U S A (2007) 0.98

Rac1 signaling modulates BCL-6-mediated repression of gene transcription. Mol Cell Biol (2009) 0.96

PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol Cell Biol (2009) 0.94

Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation. Blood (2013) 0.93

Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. J Virol (2006) 0.93

BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner. J Biol Chem (2008) 0.90

HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation. PLoS One (2015) 0.89

T follicular helper cells, T follicular regulatory cells and autoimmunity. Int Immunol (2015) 0.87

Molecular regulation of cytokine gene expression during the immune response. J Clin Immunol (1999) 0.86

Molecular pathology of lymphoma. Eye (Lond) (2012) 0.86

The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Blood (2007) 0.84

Molecular definition of the germinal centre stage of B-cell differentiation. Philos Trans R Soc Lond B Biol Sci (2001) 0.83

Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment. J Immunol (2009) 0.83

PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas. Proc Natl Acad Sci U S A (2012) 0.83

Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations. J Cell Biochem (2010) 0.83

Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters. Nucleic Acids Res (2012) 0.82

Epigenetic regulation of B lymphocyte differentiation, transdifferentiation, and reprogramming. Comp Funct Genomics (2012) 0.81

RNA-binding protein hnRNPLL regulates mRNA splicing and stability during B-cell to plasma-cell differentiation. Proc Natl Acad Sci U S A (2015) 0.80

Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions. Clin Cancer Res (2012) 0.79

The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. PLoS One (2014) 0.78

BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells. Int J Cancer (2009) 0.78

Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation. World Allergy Organ J (2008) 0.77

The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases. Biochim Biophys Acta (2014) 0.76

The Relationship between RUVBL1 (Pontin, TIP49, NMP238) and BCL6 in Benign and Malignant Human Lymphoid Tissues. Biochem Biophys Rep (2016) 0.75

Deletion of AU-rich elements within the Bcl2 3'UTR reduces protein expression and B cell survival in vivo. PLoS One (2015) 0.75

The transcriptional repressor HIC1 regulates intestinal immune homeostasis. Mucosal Immunol (2017) 0.75

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32

The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34

A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64

Kidney transplantation under FK 506. JAMA (1990) 7.45

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med (2001) 6.66

Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (1997) 6.58

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity (2000) 5.36

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83

A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature (1990) 4.69

Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Signatures of the immune response. Immunity (2001) 3.66

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol (1996) 2.53

Catabolite repression mediated by the CcpA protein in Bacillus subtilis: novel modes of regulation revealed by whole-genome analyses. Mol Microbiol (2001) 2.51

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39

A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain. Cell (1988) 2.32

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

Enzymatic deamidation of methyl-accepting chemotaxis proteins in Escherichia coli catalyzed by the cheB gene product. Proc Natl Acad Sci U S A (1983) 2.30

Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol (2000) 2.28

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med (1983) 2.27

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22

Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19

Stimulus-induced changes in methylesterase activity during chemotaxis in Escherichia coli. J Biol Chem (1984) 2.17

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03

Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03

Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96

Transcriptional repression by the proto-oncogene BCL-6. Oncogene (1996) 1.94

The methyl-accepting chemotaxis proteins of Escherichia coli. Identification of the multiple methylation sites on methyl-accepting chemotaxis protein I. J Biol Chem (1982) 1.87

Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci U S A (1999) 1.86

CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry (1998) 1.77

Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75

Investigating the thyroid nodule. BMJ (2009) 1.73

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69

CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem (1999) 1.64

Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63

The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60

Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol (1990) 1.60

Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59

T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci U S A (1998) 1.58

Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur J Immunol (1998) 1.58

Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56

Sensory adaptation in bacterial chemotaxis: regulation of demethylation. J Bacteriol (1985) 1.55

Ambiguous coronary angiography: clinical utility of intravascular ultrasound. Cathet Cardiovasc Diagn (1992) 1.54

Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53

Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52

Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51

V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J Immunol (1990) 1.49

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48

Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48

Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol (1998) 1.46

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45

Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci U S A (1993) 1.44

Adaptation in bacterial chemotaxis: CheB-dependent modification permits additional methylations of sensory transducer proteins. Cell (1982) 1.44

Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44

Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43

Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43

Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43

The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia (2011) 1.43

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Novel in vitro model for high-rate IgA class switching. J Immunol (1995) 1.41

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry (1999) 1.41

Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40

Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc Natl Acad Sci U S A (1987) 1.40

Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest (2001) 1.40

Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. EMBO J (1986) 1.40

Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39

Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39

Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39

Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39

Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39

Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38

Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol (1993) 1.36

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J Exp Med (1996) 1.34

Characterization of multiple immunoglobulin mu-chains synthesized by two clones of a B cell lymphoma. J Immunol (1980) 1.33

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32